“There are two elements that I’m familiar with which relate to Sigilon in particular. We have a technology that hides implants from the immune system so that the immune system won’t attack those implants. That means for the first time now we can manufacture cellular implants so you can do things like the artificial pancreas, which is what we did with Eli Lilly & Co.. Or you can manufacture implants that become cell factories, which can do things like treat hemophilia by manufacturing Factor VIII or Factor IX.”